Arkolith/Insider Trading/FLXN/Form 4

Muzikant Adam

Chief Business OfficerFlexion Therapeutics Inc (FLXN) · full profile →Form 4 · filed Nov 19, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
1 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 19, 2021Disposed to issuer(D)104K$8.50$881K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 19, 2021Disposed to issuer(D)20K——0
Nov 19, 2021Disposed to issuer(D)40K——0
Nov 19, 2021Disposed to issuer(D)25K——0
Nov 19, 2021Disposed to issuer(D)17K——0
Nov 19, 2021Disposed to issuer(D)11K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-065711) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML